HWAM
Hennion & Walsh Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-43,968
| Closed | -$409K | – | 855 |
|
|
2024
Q3 | $409K | Sell |
43,968
-4,618
| -10% | -$42.9K | 0.02% | 665 |
|
|
2024
Q2 | $452K | Sell |
48,586
-411
| -0.8% | -$3.82K | 0.02% | 616 |
|
|
2024
Q1 | $486K | Buy |
48,997
+6,155
| +14% | +$61K | 0.03% | 574 |
|
|
2023
Q4 | $138K | Sell |
42,842
-52,466
| -55% | -$169K | 0.01% | 798 |
|
|
2023
Q3 | $506K | Sell |
95,308
-7,105
| -7% | -$37.7K | 0.03% | 515 |
|
|
2023
Q2 | $976K | Sell |
102,413
-34,391
| -25% | -$328K | 0.06% | 377 |
|
|
2023
Q1 | $1.51M | Buy |
136,804
+4,032
| +3% | +$44.4K | 0.09% | 262 |
|
|
2022
Q4 | $1.97M | Buy |
132,772
+42,508
| +47% | +$629K | 0.12% | 210 |
|
|
2022
Q3 | $1.73M | Sell |
90,264
-2,389
| -3% | -$45.7K | 0.11% | 211 |
|
|
2022
Q2 | $1.97M | Buy |
92,653
+5,284
| +6% | +$113K | 0.12% | 205 |
|
|
2022
Q1 | $1.68M | Buy |
87,369
+22,021
| +34% | +$424K | 0.09% | 247 |
|
|
2021
Q4 | $1.36M | Buy |
65,348
+34,752
| +114% | +$721K | 0.07% | 298 |
|
|
2021
Q3 | $731K | Buy |
30,596
+10,477
| +52% | +$250K | 0.04% | 425 |
|
|
2021
Q2 | $549K | Buy |
+20,119
| New | +$549K | 0.03% | 504 |
|